Cardiovascular morbidity

Disease

5 papers3 findings

  • Humans1
  • Animals1

Interventions

1

Antihypertensive agents

downin humans2

2 studies
  1. Antihypertensive agents decrease cardiovascular morbidity in humans.

    “The available evidence in individuals aged> 80 years seems to indicate that antihypertensive treatment results in a reduction of cardiovascular morbidity and mortality.”

    Review

    Hypertension in older adults

    Hipertension y riesgo vascular1 Jan 2017

  2. Antihypertensive agents decrease cardiovascular morbidity in humans.

    “Medical treatment of hypertension reduces cardiovascular morbidity and mortality in the elderly”

    Review

    Management of hypertension in the elderly

    Nature reviews. Cardiology13 Mar 2012

More on Antihypertensive agents

Associations

1

Pulse pressure

upin humans1

1 study
  1. Pulse pressure raises the risk of cardiovascular morbidity in humans.

    “stressed the importance of PP as an independent risk factor for cardiovascular morbidity and mortality”

    Review

    Pulse pressure in the therapeutic management of hypertension?

    Herz1 May 2004

More on Pulse pressure

Funding

2 grants since 2023

National Heart, Lung, and Blood InstituteUS$2.7m

Latest

Nov 2025: 17Dec 2025: 2Jan 2026: 2Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 6Aug 2026: 14Sep 2026: 18Oct 2026: 867 in 12 months
Journal of the American Heart Association

Long COVID linked to new high blood pressure in adults

The adjusted hazard ratio—a comparison of rates over time—was 1.14 for new high blood pressure in adults with versus without a long COVID diagnosis.The adjusted hazard ratio—a comparison of rates over time—was 1.14 for new high blood pressure in adults with versus without a long COVID diagnosis.

Cohort study of 1,221,570 peoplePopulations